Royalty Report: Drugs, Therapeutic, Disease – Collection: 243431

$150.00

Curated Royalty Rate Report
Created On: 2020-07-15, Record Count: 7

Description

This collection of transactions and supporting information was developed using our AI algorithm to curate similar royalty reports into a cohesive collection to support your licensing, transfer pricing or other transaction scenarios where documented royalty rates and/or deal terms are important.
Created On: 2020-07-15
Record Count: 7

Primary Industries

  • Drugs
  • Therapeutic
  • Disease
  • DNA
  • Genome
  • Biotechnology
  • Agriculture
  • Forestry and Fishing
  • Agriculture Forestry & Fishing
  • Animal Production
  • Aquaculture

IPSCIO Report Record List

Below you will find the records curated into this collection.  This summary includes the complete licensed property description so that you can review and determine if this collection covers the topics, technology or transaction type that is relevant for your needs.  The full report will include all relevant deal data such as the royalty base, agreement date, term description, royalty rates and other deal terms.  For reference, here is a sample of a full IPSCIO curated royalty rate report: Sample Report

IPSCIO Record ID: 243431

License Grant
The general purpose of the exclusive channel collaboration described in this Agreement will be to use the Licensor Channel Technology to research, develop and Commercialize products for use in the Field.

Licensor grants a world-wide license under the Licensor IP to research, develop, use, make, have made, import, export, market, sell, and offer for sale Licensee Products in the Field in the Territory.

Licensor grants a non-exclusive license to use and display the Licensor Trademarks, solely in connection with the Commercialization of Licensee Products in the promotional materials, packaging, and labeling for Licensee Products.

This agreement also includes a non-exclusive grant back to Licensor.

License Property
Licensor has expertise in and owns or controls proprietary technology relating to the identification, design and production of genetically modified cells and DNA vectors, and the control of peptide expression.

Licensor Channel Technology means Licensors current and future technology directed towards the design, identification, culturing, and/or production of genetically modified cells, including without limitation the technology embodied in the Licensor Materials and the Licensor IP, and specifically including without limitation the following of Licensors platform areas and capabilities: (1) UltraVector®, (2) LEAP™, (3) DNA and RNA MOD engineering, (4) protein engineering, (5) transcription control chemistry, (6) genome engineering, and (7) cell system engineering.

Licensee Product means any product in the Field that is created, produced, developed, or identified in whole or in part, directly or indirectly, by or on behalf of Licensee during the Term through use or practice of Licensor Channel Technology, Licensor IP, or the Licensor Materials.

Field of Use
The Field means in humans the treatment of Ophthalmic-Local Diseases via administration of a Gene Therapeutic, and/or the treatment of Ophthalmic-Systemic Diseases via administration of a Gene Therapeutic without treating any broader systemic disease, including any systemic diseases associated with or causing such Ophthalmic-Systemic Disease.

IPSCIO Record ID: 280830

License Grant
Licensor grants a license under the Licensor IP to research, develop, use, make, have made, sell, and offer for sale Licensee, an affiliate, Products in the Field in the Territory.

Licensor grants a non-exclusive license to use and display the Licensor Trademarks, solely in connection with the Commercialization of Licensor Products in the promotional materials, packaging, and labeling for Licensee Products.

Licensor grants a non-exclusive license under the Licensor IP to use, make, have made, sell, and offer for sale Licensee Products for Permitted Ancillary Commercial Uses in the Territory.

License Property
Licensor has expertise in and owns or controls proprietary technology relating to the identification, design and production of genetically modified cells and DNA vectors, and the control of peptide expression.

Licensor Channel Technology means Licensors current and future technology directed towards the design, identification, culturing, and/or production of genetically modified cells.

Licensee Product means any product in the Field that is created, produced, developed, or identified in whole or in part, directly or indirectly, by or on behalf of Licensee during the Term through use or practice of Licensor Channel Technology, Licensor IP, or the Licensor Materials.

Channel-Related Program IP is all Inventions made with, using, or otherwise incorporating Licensor Channel Technology, together with all Patent rights and other intellectual property rights therein.

Alkaloid Program means the channel collaboration between the Parties as established and governed by this Agreement.

Licensor Trademarks means those trademarks related to the Licensor Channel Technology.

Field of Use
Field means the fermentative production of Alkaloids through genetically modified cell-lines and substrate feeds for use as Active Pharmaceutical Ingredients or as commercially-sold intermediates in the manufacture of Active Pharmaceutical Ingredients. The Field specifically excludes the use of Alkaloids for the manufacture of diacylhydrazines or any other molecule that controls an ecdysone-based switch.

IPSCIO Record ID: 299

License Grant
The Licensor hereby grants to the Licensee a License under the Licensor IP to research, develop, use, make, have made, sell, import, and offer for sale Licensee Products in the Field in the worldwide territory.

The Licensor hereby grants to the Licensee a non-exclusive, royalty-free License to use and display the Trademarks, solely in connection with the Commercialization of Licensee Products in the promotional materials, packaging, and labeling.

License Property
Licensor has expertise in and owns or controls proprietary technology relating to the identification, design and production of genetically modified cells and DNA vectors, and the control of peptide expression

Licensor Channel Technology means Licensor's current and future technology directed towards the design, identification, culturing, and/or production of genetically modified cells.

Such License shall be exclusive, even as to the Licensor, with respect to any development, selling, making or having made using (except for uses in connection with research), importing, offering for sale or other Commercialization of Licensee Products in the Field, and shall be otherwise non-exclusive.

Field of Use
Field means the development, breeding, hatching, and farming of genetically modified finfish to be used for human food consumption.

The Licensee is a company involved in bringing together biological sciences and molecular technology to enable an aquaculture industry capable of large-scale, efficient, and environmentally sustainable production of high quality seafood.

IPSCIO Record ID: 27767

License Grant
The Licensor and the Belgium Licensor grant the Licensee an exclusive license under the IP to research, develop, use, import, export, make, have made, sell, and offer for sale Licensor Products in the Field in the Territory.

The Licensors grant the Licensee a non-exclusive, royalty-free license to use and display the Licensors Trademarks solely in connection with the Commercialization of Licensor Products.

License Property
The Licensor owns or controls proprietary technology relating to the identification, design and production of genetically modified cells, DNA vectors and in vivo control of expression.

The Licensor Subsidiary controls proprietary technology known as AG013 and a related L. lactis expression platform for the treatment of diseases and conditions of the oral cavity, throat, and esophagus.

Field of Use
The Licensors grant an exclusive license in the Field under the AG013 Regulatory Rights, including an exclusive right in the Field to make reference to for purposes of conducting clinical trials and obtaining regulatory approval for AG013 as a Licensee Product.

IPSCIO Record ID: 128301

License Grant
For the Licensee products, Licensor grants a non-exclusive, non-transferable, worldwide license, without the right to grant sublicenses, under Licensor Technology and Licensor Patents to perform research and preclinical development in the Field during the research term using Licensee research genes.

Licensor grants a non-exclusive, non-transferable options to obtain licenses for up to three (3) Licensee research genes exercisable during the research term of this Agreement.

Licensor grants an exclusive worldwide license, with the right to grant sublicenses, under Licensor Technology and Patents to research, develop, make, have made, use, import, export, offer to sell and sell such exclusive Licensee products in the field.

License Property
The Licensors patents include the Delivery of Exogenous DNA Sequences in a Mammal and the Production of Pharmaceutical-Grade Plasmid DNA.
Field of Use
The field is the intervention, treatment and/or prevention of a disease or disorder in humans by Gene therapy.

IPSCIO Record ID: 203979

License Grant
Licensor grants a nonexclusive, non-transferable, worldwide license, without the right to grant sublicenses, under Licensors technology and patents to perform research and preclinical development in the field during the research term using Licensee research genes.

Licensor grants non-exclusive, non-transferable options to obtain licenses for up to three (3) Licensee identified Research Genes exercisable during the research term of this Agreement.

With respect to exclusive Licensee products directed to a Licensee research gene for which Licensee has exercised an option Licensor is obligated to grant a license.  Licensor grants to Licensee an exclusive worldwide license under Licensor technology and patents to research, develop, make, have made, use, import, export, offer to sell and sell such exclusive Licensee products in the field.

License Property
The Licensed patents include the Delivery of Exogenous DNA Sequences in a Mammal and the Production of Pharmaceutical-Grade Plasmid DNA.
Field of Use
The field is the intervention, treatment and/or prevention of a disease or disorder in humans by Gene therapy.

IPSCIO Record ID: 294014

License Grant
Licensor, a medical research centers, grants an exclusive license under the Licensed Patent Rights in the Licensed Territory to make and have made, to use and have used, to sell and have sold, to offer to sell, and to import any Licensed Products in the Licensed Fields of Use and to practice and have practiced any Licensed Processes in the Licensed Fields of Use.
License Property
The patents and patent applications relate to Modified Adena-Associated Virus Vector Capable of Expression from a Novel Promoter.

Adeno-associated viruses are small viruses that infect humans and some other primate species. They belong to the genus Dependoparvovirus, which in turn belongs to the family Parvoviridae.

Field of Use
The field of use is the development of compositions and methods utilizing Adeno-Associated Viral Vectors embodied in the Licensed Patent Rights which are useful in the treatment and prophylaxis of human and animal diseases, and does not include compositions and methods for the treatment and prophylaxis of cystic fibrosis.

Cystic fibrosis is a hereditary disease that affects the lungs and digestive system. The body produces thick and sticky mucus that can clog the lungs and obstruct the pancreas. Cystic fibrosis (CF) can be life-threatening, and people with the condition tend to have a shorter-than-normal life span.

Disclaimer: The information gathered from RoyaltySource® database was sourced from the U.S. Securities and Exchange Commission EDGAR Filings and other public records. While we believe the sources to be reliable, this does not guarantee the accuracy or completeness of the information provided. Further, the information is supplied as general guidance and is not intended to represent or be a substitute for a detailed analysis or professional judgment. This information is for private use only and may not be resold or reproduced without permission.